Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 11.44x is 32% below its estimated 5-year average of 16.93x, near the low end of its estimated 5-year range (5.96x–312.69x).
As of 2026-10-06T18:52:39.295Z. 4.61% above its estimated 12-month average of 10.94x.
Calculation as of: 2026-10-06T18:52:39.295Z.
Quote observation: 2026-10-06T18:50:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 808c910da90db3ff71e8c79107ad4b097b7d68dd977fffb6b2b5e43025488f63
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
11.44x
EV/EBITDA RATIO AVG TTM
10.94x
EV/EBITDA RATIO AVG 3Y
11.29x
EV/EBITDA RATIO AVG 5Y
16.93x
EV/EBITDA RATIO AVG 10Y
39.86x
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+4.61%
CURRENT VS 3Y AVG
+1.37%
CURRENT VS 5Y AVG
-32.44%
CURRENT VS 10Y AVG
-71.30%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.76x
median of 217 covered companies
CURRENT VS SECTOR MEDIAN
-27.41%
vs the sector median at left
Pacira BioSciences, Inc.
Market Cap
$979.09M
EV/EBITDA Ratio
11.44x
TTM Avg
10.94x
3Y Avg
11.29x
5Y Avg
16.93x
Market Cap
$985.00M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$988.52M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$988.20M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$990.27M
EV/EBITDA Ratio
4.88x
TTM Avg
6.06x
3Y Avg
6.06x
5Y Avg
6.06x
Market Cap
$1.01B
EV/EBITDA Ratio
N/A
TTM Avg
2.11x
3Y Avg
2.11x
5Y Avg
2.11x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | $979.09M | 11.44x | 10.94x | 11.29x | 16.93x |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $985.00M | N/A | N/A | N/A | N/A |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $988.52M | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $988.20M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $990.27M | 4.88x | 6.06x | 6.06x | 6.06x |
| Aktis Oncology, Inc. (AKTS)vs › | $965.04M | N/A | N/A | N/A | N/A |
| Vor Biopharma Inc. (VOR)vs › | $995.31M | N/A | N/A | N/A | N/A |
| Savara Inc. (SVRA)vs › | $953.94M | N/A | N/A | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.01B | N/A | 2.11x | 2.11x | 2.11x |
| Immatics N.V. (IMTX)vs › | $1.01B | N/A | 21.42x | 21.42x | 21.42x |
At 11.4, EV/EBITDA is below its estimated 12-year median — higher than 12% of readings in its estimated 12-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 12-year low
6.0
median
49.5
estimated 12-year high
1006.8
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-10-05 | 11.73x |
| 2026-10-02 | 11.80x |
| 2026-10-01 | 11.72x |
| 2026-09-30 | 11.73x |
| 2026-09-29 | 11.97x |
| 2026-09-28 | 11.87x |
| 2026-09-25 | 11.76x |
| 2026-09-24 | 11.93x |
| 2026-09-23 | 11.57x |
| 2026-09-22 | 11.60x |
| 2026-09-21 | 11.37x |
| 2026-09-18 | 11.59x |
| 2026-09-17 | 11.51x |
| 2026-09-16 | 11.68x |
| 2026-09-15 | 11.36x |
| 2026-09-14 | 11.59x |
| 2026-09-11 | 11.86x |
| 2026-09-10 | 11.78x |
| 2026-09-09 | 12.06x |
| 2026-09-08 | 12.05x |
| 2026-09-04 | 12.24x |
| 2026-09-03 | 12.34x |
| 2026-09-02 | 12.33x |
| 2026-09-01 | 12.29x |
| 2026-08-31 | 12.07x |
| 2026-08-28 | 12.01x |
| 2026-08-27 | 12.04x |
| 2026-08-26 | 12.07x |
| 2026-08-25 | 11.92x |
| 2026-08-24 | 11.66x |
| 2026-08-21 | 11.59x |
| 2026-08-20 | 11.26x |
| 2026-08-19 | 11.47x |
| 2026-08-18 | 11.33x |
| 2026-08-17 | 11.03x |
| 2026-08-14 | 10.94x |
| 2026-08-13 | 11.01x |
| 2026-08-12 | 11.21x |
| 2026-08-11 | 11.47x |
| 2026-08-10 | 11.49x |
| 2026-08-07 | 11.72x |
| 2026-08-06 | 11.94x |
| 2026-08-05 | 11.66x |
| 2026-08-04 | 12.27x |
| 2026-08-03 | 12.02x |
| 2026-07-31 | 11.83x |
| 2026-07-30 | 12.03x |
| 2026-07-29 | 11.83x |
| 2026-07-28 | 11.98x |
| 2026-07-27 | 11.85x |
| 2026-07-24 | 11.64x |
| 2026-07-23 | 11.66x |
| 2026-07-22 | 11.54x |
| 2026-07-21 | 11.61x |
| 2026-07-20 | 11.45x |
| 2026-07-17 | 11.55x |
| 2026-07-16 | 11.54x |
| 2026-07-15 | 11.44x |
| 2026-07-14 | 11.33x |
| 2026-07-13 | 11.52x |
| 2026-07-10 | 11.50x |
| 2026-07-09 | 11.51x |
| 2026-07-08 | 11.51x |
| 2026-07-07 | 11.62x |
| 2026-07-06 | 11.54x |
| 2026-07-02 | 11.47x |
| 2026-07-01 | 11.34x |
| 2026-06-30 | 11.46x |
| 2026-06-29 | 11.36x |
| 2026-06-26 | 11.41x |
| 2026-06-25 | 11.10x |
| 2026-06-24 | 10.95x |
| 2026-06-23 | 10.79x |
| 2026-06-22 | 10.50x |
| 2026-06-18 | 10.37x |
| 2026-06-17 | 10.48x |
| 2026-06-16 | 10.54x |
| 2026-06-15 | 10.51x |
| 2026-06-12 | 10.60x |
| 2026-06-11 | 10.74x |
| 2026-06-10 | 10.76x |
| 2026-06-09 | 10.68x |
| 2026-06-08 | 10.56x |
| 2026-06-05 | 10.52x |
| 2026-06-04 | 10.49x |
| 2026-06-03 | 10.36x |
| 2026-06-02 | 10.34x |
| 2026-06-01 | 10.59x |
| 2026-05-29 | 10.69x |
| 2026-05-28 | 10.85x |
| 2026-05-27 | 10.98x |
| 2026-05-26 | 11.10x |
| 2026-05-22 | 10.73x |
| 2026-05-21 | 10.78x |
| 2026-05-20 | 10.61x |
| 2026-05-19 | 10.36x |
| 2026-05-18 | 10.41x |
| 2026-05-15 | 10.48x |
| 2026-05-14 | 10.80x |
| 2026-05-13 | 10.62x |
| 2026-05-12 | 10.55x |
| 2026-05-11 | 10.51x |
| 2026-05-08 | 10.66x |
| 2026-05-07 | 10.84x |
| 2026-05-06 | 10.86x |
| 2026-05-05 | 11.25x |
| 2026-05-04 | 11.21x |
| 2026-05-01 | 11.12x |
| 2026-04-30 | 12.53x |
| 2026-04-29 | 12.39x |
| 2026-04-28 | 12.50x |
| 2026-04-27 | 12.55x |
| 2026-04-24 | 12.15x |
| 2026-04-23 | 12.48x |
| 2026-04-22 | 12.29x |
| 2026-04-21 | 12.20x |
| 2026-04-20 | 12.30x |
| 2026-04-17 | 12.23x |
| 2026-04-16 | 11.90x |
| 2026-04-15 | 11.73x |
| 2026-04-14 | 11.85x |
| 2026-04-13 | 11.97x |
| 2026-04-10 | 11.87x |
| 2026-04-09 | 11.88x |
| 2026-04-08 | 11.66x |
| 2026-04-07 | 11.38x |
| 2026-04-06 | 11.28x |
| 2026-04-02 | 11.45x |
| 2026-04-01 | 11.48x |
| 2026-03-31 | 11.41x |
| 2026-03-30 | 11.67x |
| 2026-03-27 | 11.52x |
| 2026-03-26 | 11.68x |
| 2026-03-25 | 11.75x |
| 2026-03-24 | 11.64x |
| 2026-03-23 | 11.43x |
| 2026-03-20 | 11.22x |
| 2026-03-19 | 11.40x |
| 2026-03-18 | 11.19x |
| 2026-03-17 | 11.15x |
| 2026-03-16 | 11.44x |
| 2026-03-13 | 11.66x |
| 2026-03-12 | 11.77x |
| 2026-03-11 | 11.50x |
| 2026-03-10 | 11.35x |
| 2026-03-09 | 11.27x |
| 2026-03-06 | 11.18x |
| 2026-03-05 | 11.51x |
| 2026-03-04 | 11.51x |
| 2026-03-03 | 11.22x |
| 2026-03-02 | 10.90x |
| 2026-02-27 | 11.14x |
| 2026-02-26 | 9.68x |
| 2026-02-25 | 9.97x |
| 2026-02-24 | 9.95x |
| 2026-02-23 | 9.85x |
| 2026-02-20 | 9.89x |
| 2026-02-19 | 9.88x |
| 2026-02-18 | 9.82x |
| 2026-02-17 | 9.73x |
| 2026-02-13 | 9.40x |
| 2026-02-12 | 9.29x |
| 2026-02-11 | 9.39x |
| 2026-02-10 | 9.22x |
| 2026-02-09 | 9.17x |
| 2026-02-06 | 9.14x |
| 2026-02-05 | 8.93x |
| 2026-02-04 | 9.04x |
| 2026-02-03 | 9.15x |
| 2026-02-02 | 9.22x |
| 2026-01-30 | 8.99x |
| 2026-01-29 | 8.84x |
| 2026-01-28 | 8.94x |
| 2026-01-27 | 8.76x |
| 2026-01-26 | 8.98x |
| 2026-01-23 | 9.03x |
| 2026-01-22 | 9.07x |
| 2026-01-21 | 8.89x |
| 2026-01-20 | 8.57x |
| 2026-01-16 | 8.53x |
| 2026-01-15 | 9.03x |
| 2026-01-14 | 9.56x |
| 2026-01-13 | 9.35x |
| 2026-01-12 | 9.79x |
| 2026-01-09 | 9.99x |
| 2026-01-08 | 10.83x |
| 2026-01-07 | 10.82x |
| 2026-01-06 | 10.59x |
| 2026-01-05 | 10.52x |
| 2026-01-02 | 10.30x |
| 2025-12-31 | 10.78x |
| 2025-12-30 | 10.85x |
| 2025-12-29 | 10.84x |
| 2025-12-26 | 10.99x |
| 2025-12-24 | 10.83x |
| 2025-12-23 | 10.73x |
| 2025-12-22 | 10.83x |
| 2025-12-19 | 10.94x |
| 2025-12-18 | 10.78x |
| 2025-12-17 | 11.01x |
| 2025-12-16 | 10.88x |
| 2025-12-15 | 11.05x |
| 2025-12-12 | 10.92x |
| 2025-12-11 | 10.73x |
| 2025-12-10 | 10.55x |
| 2025-12-09 | 10.41x |
| 2025-12-08 | 10.29x |
| 2025-12-05 | 10.15x |
| 2025-12-04 | 10.14x |
| 2025-12-03 | 10.21x |
| 2025-12-02 | 10.17x |
| 2025-12-01 | 10.05x |
| 2025-11-28 | 10.01x |
| 2025-11-26 | 10.09x |
| 2025-11-25 | 9.87x |
| 2025-11-24 | 9.87x |
| 2025-11-21 | 9.83x |
| 2025-11-20 | 9.75x |
| 2025-11-19 | 10.26x |
| 2025-11-18 | 10.28x |
| 2025-11-17 | 10.11x |
| 2025-11-14 | 10.08x |
| 2025-11-13 | 10.02x |
| 2025-11-12 | 10.10x |
| 2025-11-11 | 10.19x |
| 2025-11-10 | 9.84x |
| 2025-11-07 | 9.50x |
| 2025-05-08 | 292.49x |
| 2025-05-07 | 294.94x |
| 2025-05-06 | 294.67x |
| 2025-05-05 | 300.65x |
| 2025-05-02 | 306.44x |
| 2025-05-01 | 309.16x |
| 2025-04-30 | 310.52x |
| 2025-04-29 | 311.42x |
| 2025-04-28 | 312.69x |
| 2025-04-25 | 299.83x |
| 2025-04-24 | 302.37x |
| 2025-04-23 | 295.12x |
| 2025-04-22 | 297.39x |
| 2025-04-21 | 301.46x |
| 2025-04-17 | 290.14x |
| 2025-04-16 | 288.51x |
| 2025-04-15 | 292.22x |
| 2025-04-14 | 293.04x |
| 2025-04-11 | 289.32x |
| 2025-04-10 | 281.44x |
| 2025-04-09 | 300.92x |
| 2025-04-08 | 304.81x |
| 2025-04-07 | 274.38x |
| 2025-04-04 | 276.10x |
| 2025-04-03 | 286.88x |
| 2025-04-02 | 292.31x |
| 2025-04-01 | 284.89x |
| 2025-03-31 | 291.95x |
| 2025-03-28 | 292.49x |
| 2025-03-27 | 296.03x |
| 2025-03-26 | 288.06x |
| 2025-03-25 | 289.14x |
| 2025-03-24 | 291.86x |
Showing the most recent 260 of 2,355 data points. The chart above shows the full history.
